E. A. Ulesova
E. A. Ulesova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Mariyko
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
2 shared publications - A. V. Parshin
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
2 shared publications - D. D. Serpukhin
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
2 shared publications - Evgeny Georgievich Sokolovich
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
2 shared publications - Vladimir D. Parshin
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications M. A. Ursov
National Medical Research Center of Phthisiopulmonology and Infectious Diseases; Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (4) , 7-16
SMART 2.0 Scale for Quantitative Assessment of Anatomical and Functional Complexity in Patients with Cicatricial Tracheal Stenosis: Development and Primary Validation
Background: In cicatricial tracheal stenosis, treatment complexity is determined by the anatomy of the lesion and previous interventions. A quantitative assessment of these features is necessary to compare patients and follow changes during treatment. Objective: To evaluate the SMART 2.0 scale and its association with treatment modalities and outcomes, and to describe changes in scores across successive hospitalizations. Material and methods: A registry of 1209 patients who underwent surgery by a single surgical team in 2004–2024 was analyzed retrospectively. The five SMART 2.0 domains integrate clinical history and current findings in a score of 0–20 points. The registered analysis plan (https://osf.io/65zxb) used Jonckheere–Terpstra and Cochran–Armitage tests and area under the ROC curve (AUC). Results: The median baseline SMART 2.0 score increased from 6.5 (5–8) in the isolated endoscopic treatment category to 9 (7–10) in the category combining resection with staged tracheoplasty (z = 9.213; p < 0.001). AUC was 0.60 (95% CI, 0.56–0.65) for the full composite and 0.55 (0.49–0.60) after removing the hospitalization-count component, with no monotonic frequency trend ( p = 0.104). An unfavorable final status was recorded in 25 of 820 patients; AUC was 0.63 (0.52–0.74). Discussion: Higher baseline scores corresponded to more staged treatment. Combining clinical history with current anatomy provides a way to describe the postoperative situation while retaining information on prior treatment. Predictive performance was limited: AUC was below the registered criterion of 0.70 for both outcomes. Conclusion: SMART 2.0 warrants further evaluation as a standardized description of complexity during treatment for cicatricial tracheal stenosis. The score showed preliminary correspondence with treatment categories within one team. The prognostic hypotheses were not confirmed; independent validation is needed for treatment decisions and assessment of clinically meaningful change.
- 9 November 2026
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 11 (4) , 7-16
Open AccessSMART 2.0 Scale for Quantitative Assessment of Anatomical and Functional Complexity in Patients with Cicatricial Tracheal Stenosis: Development and Primary Validation
Background: In cicatricial tracheal stenosis, treatment complexity is determined by the anatomy of the lesion and previous interventions. A quantitative assessment of these features is necessary to compare patients and follow changes during treatment. Objective: To evaluate the SMART 2.0 scale and its association with treatment modalities and outcomes, and to describe changes in scores across successive hospitalizations. Material and methods: A registry of 1209 patients who underwent surgery by a single surgical team in 2004–2024 was analyzed retrospectively. The five SMART 2.0 domains integrate clinical history and current findings in a score of 0–20 points. The registered analysis plan (https://osf.io/65zxb) used Jonckheere–Terpstra and Cochran–Armitage tests and area under the ROC curve (AUC). Results: The median baseline SMART 2.0 score increased from 6.5 (5–8) in the isolated endoscopic treatment category to 9 (7–10) in the category combining resection with staged tracheoplasty (z = 9.213; p < 0.001). AUC was 0.60 (95% CI, 0.56–0.65) for the full composite and 0.55 (0.49–0.60) after removing the hospitalization-count component, with no monotonic frequency trend ( p = 0.104). An unfavorable final status was recorded in 25 of 820 patients; AUC was 0.63 (0.52–0.74). Discussion: Higher baseline scores corresponded to more staged treatment. Combining clinical history with current anatomy provides a way to describe the postoperative situation while retaining information on prior treatment. Predictive performance was limited: AUC was below the registered criterion of 0.70 for both outcomes. Conclusion: SMART 2.0 warrants further evaluation as a standardized description of complexity during treatment for cicatricial tracheal stenosis. The score showed preliminary correspondence with treatment categories within one team. The prognostic hypotheses were not confirmed; independent validation is needed for treatment decisions and assessment of clinically meaningful change.
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Restenosis rate after surgical and endoscopic treatment of cicatricial tracheal stenosis: a systematic review and meta-analysis
Objective. To estimate the rate of restenosis after surgical and endoscopic treatment of acquired benign tracheal stenosis in adults with separate analyses by approach, etiology, and follow-up. Material and methods. Systematic searching was performed in PubMed/MEDLINE, EuropePMC, Cochrane CENTRAL, eLibrary.ru, BASE, LILACS databases and trial registries (2005–2025). Cohorts ≥100 patients (primary set) and 50–99 (sensitivity set) were eligible. Two reviewers performed blinded screening and extraction (Cohen’s κ=0.808); the risk of bias was assessed with ROBINS-I. Proportions were pooled under random effects with stratification by approach, etiology and follow-up. Results. Primary set comprised 14 cohorts (3.213 patients; 690 events); sensitivity set — 25 cohorts. Heterogeneity was high (I²=98.0%). The pooled restenosis rate was 16.8% (95% CI 13.5–20.6; 95% PI 1.1–78.2). There were the following values depending on approach: circumferential tracheal resection 7.8%, mixed 10.0%, isolated endoscopy 47.6% (p<0.0001). Idiopathic subglottic cicatricial stenosis of the trachea comprised 58.9%, PITS+PTTS — 5.7%, mixed/other — 15.3% (p<0.0001). Sensitivity set yielded 22.3%. The estimate was robust to sequential cohort exclusion (16.5–25.2%). Egger’s test showed funnel asymmetry (p=0.019) opposite to classical small-study pattern; trim-and-fill imputed no missing studies. Conclusion. The pooled 16.8% does not predict individual outcome; only the stratified estimate is clinically usable. Direct surgical-versus-endoscopic comparison on retrospective data is unsound because patient selection differs by approach. In idiopathic subglottic stenosis, the true restenosis rate under adequate prospective follow-up exceeds the primary-set estimate.
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Restenosis rate after surgical and endoscopic treatment of cicatricial tracheal stenosis: a systematic review and meta-analysis
Objective. To estimate the rate of restenosis after surgical and endoscopic treatment of acquired benign tracheal stenosis in adults with separate analyses by approach, etiology, and follow-up. Material and methods. Systematic searching was performed in PubMed/MEDLINE, EuropePMC, Cochrane CENTRAL, eLibrary.ru, BASE, LILACS databases and trial registries (2005–2025). Cohorts ≥100 patients (primary set) and 50–99 (sensitivity set) were eligible. Two reviewers performed blinded screening and extraction (Cohen’s κ=0.808); the risk of bias was assessed with ROBINS-I. Proportions were pooled under random effects with stratification by approach, etiology and follow-up. Results. Primary set comprised 14 cohorts (3.213 patients; 690 events); sensitivity set — 25 cohorts. Heterogeneity was high (I²=98.0%). The pooled restenosis rate was 16.8% (95% CI 13.5–20.6; 95% PI 1.1–78.2). There were the following values depending on approach: circumferential tracheal resection 7.8%, mixed 10.0%, isolated endoscopy 47.6% (p<0.0001). Idiopathic subglottic cicatricial stenosis of the trachea comprised 58.9%, PITS+PTTS — 5.7%, mixed/other — 15.3% (p<0.0001). Sensitivity set yielded 22.3%. The estimate was robust to sequential cohort exclusion (16.5–25.2%). Egger’s test showed funnel asymmetry (p=0.019) opposite to classical small-study pattern; trim-and-fill imputed no missing studies. Conclusion. The pooled 16.8% does not predict individual outcome; only the stratified estimate is clinically usable. Direct surgical-versus-endoscopic comparison on retrospective data is unsound because patient selection differs by approach. In idiopathic subglottic stenosis, the true restenosis rate under adequate prospective follow-up exceeds the primary-set estimate.